The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of infusional or bolus deflexifol (a novel formulation of 5FU, folinic acid, and cyclodextrin) after failure of standard treatment.
 
Philip R. Clingan
Stock and Other Ownership Interests - FivePhusion
Research Funding - FivePhusion
Patents, Royalties, Other Intellectual Property - PRCLINGAN PTY LTD
Other Relationship - FivePhusion (I)
 
Stephen P. Ackland
No Relationships to Disclose
 
Marie Ranson
Employment - FivePhusion (I)
Stock and Other Ownership Interests - Marie Ranson
Patents, Royalties, Other Intellectual Property - Marie Ranson
Other Relationship - FivePhusion (I)
 
Paul De Souza
No Relationships to Disclose
 
Ali Tafreshi
No Relationships to Disclose
 
Morteza Aghmesheh
No Relationships to Disclose
 
Daniel Brungs
No Relationships to Disclose
 
Madhu Bala Garg
No Relationships to Disclose
 
Suzanne Parker
No Relationships to Disclose
 
Rebecca Jokela
No Relationships to Disclose